EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, vol.20, no.20, pp.4305-4312, 2016 (SCI-Expanded)
Article / Article
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES
Science Citation Index Expanded (SCI-EXPANDED), Scopus
Pentraxin-3, Endothelial dysfunction, Non-alcoholic fatty liver disease, HOMEOSTASIS MODEL ASSESSMENT, C-REACTIVE PROTEIN, STEATOHEPATITIS NASH, CARDIOVASCULAR RISK, OBESITY, SENSITIVITY, ACTIVATION, SEVERITY, GLUCOSE, PTX3
Eskisehir Osmangazi University Affiliated:
OBJECTIVE: Pentraxin-3 (PTX3) is an acute-phase protein belonging to the PTX family. It has been reported that PTX-3 is significantly associated with obesity, metabolic syndrome, and cardiovascular diseases (CVD). Non-alcoholic fatty liver disease (NAFLD) is strongly associated with atherosclerosis and CVD. In this study, we aimed to investigate the relationship of PTX-3 with circulating markers of endothelial dysfunction and atherosclerosis in patients with NAFLD.